Search

Your search keyword '"Valensin, Daniela"' showing total 404 results

Search Constraints

Start Over You searched for: Author "Valensin, Daniela" Remove constraint Author: "Valensin, Daniela"
404 results on '"Valensin, Daniela"'

Search Results

153. The specificity of interaction of Zn2+, Ni2+ and Cu2+ ions with the histidine-rich domain of the TjZNT1 ZIP family transporter.

155. NMR metabolomic investigation of astrocytes interacted with Aβ42 or its complexes with either copper(II) or zinc(II)

156. Coordination of Ni2+ and Cu2+ to metal ion binding domains of E. coli SlyD protein

158. Competition between histamine-like and poly-imidazole coordination sites for Cu2+and Zn2+ions in zebra-fish peptide of prion-like proteinElectronic supplementary information (ESI) available: 1H and 13C NMR chemical shift of zf74-86 1.0 mM, pH 7.5, T298 K; UV-Vis spectra of Cu2+–zf74-86 complexes at different pH. Metal to ligand ratio = 1 : 1.1; intensity reduction of 1H–1H TOCSY cross-peaks of zf74-86 1.0 mM solutions induced by 0.3 equivalents of Cu2+, pH 3.3, T298 K; ESI-MS spectra of zf74-86. See DOI: 10.1039/c0dt00137f

159. Copper binding to chicken and human prion protein amylodogenic regions: Differences and similarities revealed by Ni2+ as a diamagnetic probe

160. The complex-formation behaviour of His residues in the fifth Cu2+binding site of human prion protein: a close lookElectronic supplementary information (ESI) available: Tables S1–S3 and Figs. S1 and S2. See DOI: 10.1039/b9nj00202b.

161. Structure and Stability of the CuIIComplexes with Tandem Repeats of the Chicken Prion.

162. Unusual binding ability of vancomycin towards Cu2ions

163. Identification of a novel high affinity copper binding site in the APP(145–155) fragment of amyloid precursor protein

164. Identification of a novel high affinity copper binding site in the APP145–155 fragment of amyloid precursor protein

165. Is the monomeric prion octapeptide repeat PHGGGWGQ a specific ligand for Cu2+ ions?

166. Impact of the peptide sequence on the coordination abilities of albumin-like tripeptides towards Cu2+, Ni2+ and Zn2+ ions. Potential albumin-like peptide chelators

167. Chiral peptide nucleic acids having thymine and adenine in their side chain as specific ligands for Ni<SUP>II</SUP> and Cu<SUP>II</SUP> †

168. Exploring the Reactions of β-Amyloid (Aβ) Peptide 1-28 with AlIII and FeIII Ions.

169. fac-(Ru(CO)3)2+ Selectively Targets the Histidine Residues of the β-Amyloid Peptide 1-28. Implications for New Alzheimer's Disease Treatments Based on Ruthenium Complexes.

170. Structural features of the Zn2+complex with the single repeat region of “prion related protein” (PrP-rel-2) of zebrafish zPrP63–70 fragmentElectronic supplementary information (ESI) available: Peptide synthesis, NMR measurements, 1H–13C HSQC spectra of the apo and metal bound zPrP63–70. See DOI: 10.1039/b907626n

171. Fine tuning the structure of the Cu2complex with the prion protein chicken repeat by proline isomerizationElectronic supplementary information ESI available: peptide synthesis, NMR measurements and 1H-13C HSQC spectra. See http://www.rsc.org/suppdata/cc/b5/b504986e/index.sht

173. Influence of membrane environments and copper ions on the structural features of amyloidogenic proteins correlated to neurodegeneration.

174. Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment.

175. A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity.

178. Probing the role of metal ions on reversible peptide–protein interactions by NMR

179. Synthesis, X-ray structure analysis and density functional study of an unusual anhydrous 5,6-dimethylbenzo-1,3-imidazolium(H3) chloride.

180. {Ru(CO)x}-core complexes with selected azoles: Synthesis, X-ray structure, spectroscopy, DFT analysis and evaluation of cytotoxic activity against human cancer cells.

181. Bioinorganic Chemistry of Parkinson's Disease: Structural Determinants for the Copper-Mediated Amyloid Formation of Alpha-Synuclein.

182. Synthesis and structural characterization of a novel phenoxazinone dye by use of a fungal laccase

183. Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease.

184. Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02.

185. Structural analysis of copper(I) interaction with amyloid β peptide.

186. Glutathione and phytochelatins jointly allow intracellular and extracellular detoxification of cadmium in the liverwort Marchantia polymorpha.

187. NMR investigations of metal interactions with unstructured soluble protein domains.

188. Copper-induced structural propensities of the amyloidogenic region of human prion protein.

189. Specific metal ion binding sites in unstructured regions of proteins.

190. Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)

191. Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases

192. Cu(II) ion interaction with teicoplanin-vancomycin’s analog

193. Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation)

194. Structural studies in solution and in the solid state on the zinc chelate of 2-hydroxy-(4-methylthio)butanoic acid, an effective mineral supplement in animal feeding

195. Specificity in the Cu2+ interactions with prion protein fragments and related His-rich peptides from mammals to fishes

196. 1H and 13C NMR study of the complex formed by copper(II) with the nucleoside antibiotic sinefungin

197. Interaction Of The Human Prion PrP(106--126) Sequence With Copper(II), Manganese(II), And Zinc(II): NMR and EPR Studies.

198. Zn(II)-alloferon complexes – Similar sequence, different coordination modes, no antibacterial activity.

199. Novel Perspective on Alzheimer's Disease Treatment: Rosmarinic Acid Molecular Interplay with Copper(II) and Amyloid β.

200. Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions.

Catalog

Books, media, physical & digital resources